InVivo Therapeutics Holdings Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. InVivo Therapeutics regular Real Value cannot be determined due to lack of data. The prevalent price of InVivo Therapeutics is $0.0. Our model calculates the value of InVivo Therapeutics from evaluating the firm fundamentals such as return on equity of -0.98, and Return On Asset of -0.54 as well as inspecting its technical indicators and probability of bankruptcy.
InVivo Therapeutics Total Value Analysis
InVivo Therapeutics Holdings is now forecasted to have valuation of (7.59 M) with market capitalization of 995.92 K, debt of 949 K, and cash on hands of 13.03 M. The negative valuation of InVivo Therapeutics may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the InVivo Therapeutics fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(7.59 M) | 995.92 K | 949 K | 13.03 M |
InVivo Therapeutics Asset Utilization
One of the ways to look at asset utilization of InVivo is to check how much profit was generated for every dollar of assets it reports. InVivo Therapeutics retains a negative application of resources of -0.54 (percent), losing $0.005371 for each dollar of resources held by the firm. Ineffective asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of InVivo Therapeutics Holdings shows how unsuccessful it operates for each dollar spent on its resources.InVivo Therapeutics Ownership Allocation
Roughly 96.54 (percent) of InVivo Therapeutics outstanding shares are held by general public with 0.02 % owned by insiders and only 3.44 pct. by outside corporations.InVivo Therapeutics Profitability Analysis
Net Loss for the year was (9.33 M) with profit before overhead, payroll, taxes, and interest of 0.InVivo Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as InVivo Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.5 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in InVivo Stock
If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |